Cyclacel Pharmaceuticals (CYCC) Collapses on Analysts' Comments

November 30, 2015 10:58 AM | 14 seconds read |
Cyclacel Pharmaceuticals CYCC shares tumbled 25.3% to 76 cents after gaining 47.8% on Friday. One analyst on a YouTube live stream on Sunday said that Cyclacel stock is worthless. Share volume totaled 2.4 million, overwhelming an all-day average of 30,000
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!